Nurosym by Parasym releases a resource on its non-invasive vagus nerve stimulation wearable, examining how the AVNT™-powered earpiece can support everyday stress management.
-- As people look for ways to support their management of everyday stress, Nurosym by Parasym has released an informational resource describing its non-invasive vagus nerve stimulation wearable as a viable option. The document explains how the device works and where it might fit for those considering alternatives outside more conventional stress-reduction routines.
For more information, visit: https://nurosym.com/blogs/nurosym-stories/nurosym-device-from-vagus-nerve-irritation-to-enhanced-well-being
Interest in non-invasive vagus nerve stimulation has grown as researchers continue to examine its possible role in supporting anxiety-related symptoms and nervous system regulation. For its own part, Parasym reports more than 60 completed clinical studies and research partnerships with institutions including Harvard and UCLA - alongside further studies currently under way.
These studies have shown promise for participants - particularly those looking for lasting results. According to Parasym, the method notably applies gentle impulses to the auricular branch of the vagus nerve, which sits near the surface of the ear. As such, VNS wearables allow users to implement this practice into a daily routine.
The Nurosym device is highlighted for applying this broader method through a specific design: the wearable is a small earpiece that clips onto the tragus, the part of the outer ear nearest the ear canal, where the vagus nerve reaches the skin. It then delivers gentle electrical pulses using Parasym's proprietary AVNT™ waveform, with the company stating that most people wear it for around 30 minutes, once or twice daily, while working, reading or watching television.
Crucially, no surgery, clinical visit, or ongoing prescription is required - a point the company emphasises as increasingly relevant for those seeking a proven method that fits around their existing schedules.
Accessibility, then, is a central quality for such users, suggests Parasym’s Head of Research Dr. Elisabetta Burchi - who notes the impact of modern VNS devices in this specific regard.
In Dr Burchi’s words: “By offering accessible, wearable and targeted treatment options, the non-invasive neuromodulatory approach can safely be combined with pharmacotherapy for a wide range of neurological, psychiatric, metabolic and inflammatory conditions to potentially revolutionise care for patients who haven't responded well to traditional therapies.”
Parasym cites its associated body of clinical research as the basis for describing Nurosym as among the more extensively studied wearable VNS devices currently available. Its resource reiterates such points while informing readers of the advantages associated with these non-invasive options as they look to fight everyday stress quickly and effectively.
Interested parties can find broader details about Parasym’s Nurosym device and the research behind it at: https://nurosym.com/
*Research referenced in this article was conducted using Parasym's neuromodulation technology under research conditions. Findings relate to specific study populations and should not be interpreted as medical claims or guaranteed individual outcomes. Nurosym is a CE-marked medical device in Europe.
Contact Info:
Name: PR Team
Email: Send Email
Organization: Nurosym by Parasym
Address: 18 Saint Cross Street 4th Floor, London, England EC1N 8UN, United Kingdom
Website: https://nurosym.com/
Source: PressCable
Release ID: 89207437
Should you come across any errors, concerns, or inconsistencies within this press release's content, we urge you to reach out without delay by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our committed team will promptly address your feedback within 8 hours and take appropriate measures to resolve any identified issues or guide you through the removal process. Providing accurate and dependable information remains our utmost priority.
